anxiety neurosis
Conditions
Interventions
experimental group:None
Sponsors
Shanghai Tongji Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: (1)Age :Adults aged between 18 and 75 years old, with no gender restrictions; (2)Patients with anxiety who are recommended for treatment with tandospirone based on Western medicine diagnosis. (3)Having at least one psychological or psychiatric scale can assess the severity of the patient 's disease(such as Self-rating Anxiety Scale ( SAS ), Hamilton Anxiety Scale ( HAMA ), 7Generalized Anxiety Disorder Scale ( GAD-7 ), etc. ) ; (4)Requires the patient to be conscious and capable of independently completing various scale assessments.; (5)Good compliance and voluntary signing of the informed consent form.
Exclusion criteria
Exclusion criteria: (1)Patients with severe or unstable internal medical diseases such as cardiovascular, liver, kidney, endocrine, hematologic, respiratory disorders, etc.; (2)Patients who are allergic to tandospirone citrate and its components. (3)Patients with a history of suicide attempts or suicidal tendencies. (4)Patients who have taken other anti-anxiety medications or psychotropic drugs within 1 month prior to enrollment. (5)Patients with severe organic diseases or other life-threatening conditions. (6)Patients with substance abuse or dependency on opioids, alcohol, etc., within the last 6 months. (7)Patients who have participated in another clinical study within the last 30 days. (8)Patients deemed unsuitable for participation in this study by the investigator.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The overall effectiveness rate of Tandospirone treatment in improving anxiety symptoms after 3 months.; | — |
Secondary
| Measure | Time frame |
|---|---|
| Patients' overall effectiveness rate of anxiety symptom improvement after 1 and 2 months of Tandospirone treatment.;The reduction rates of scores on various scales at 1, 2, and 3 months after treatment.;The difference in scale scores from baseline at 1, 2, and 3 months after treatment;;Dose changes of tandospirone in patients with different degrees of anxiety;;Combination medication usage with tandospirone;; | — |
Countries
China
Contacts
Public ContactXuemei Xie
Beijing Yaoling Medical Technology Co., LTD
Outcome results
None listed